Genotyping Assays Market Size Worth USD 58.55 Billion by 2034 | CAGR: 12.2%

The genotyping assays market size was valued at USD 20.40 billion in 2025 and is expected to reach USD 58.55 billion by 2034, according to a new study by Polaris Market Research. The study is titled "Genotyping Assays Market Share, Size, Trends, & Industry Analysis Report By Variant Type, By Technology, By Product, By End User, By Application, and By Region; Market Forecast, 2026 to 2034". It covers the products, technologies, applications, end users, and variant types that shape demand for tests that read known genetic variants.

The market is growing at a CAGR of 12.2% from 2026 to 2034, as pharmacogenomic testing, population cohorts, and companion diagnostics move genotyping into routine use. Hospitals now order drug response panels before the first prescription, and national programs are genotyping hundreds of thousands of volunteers.

Suppliers earned USD 23.32 billion from this market in 2026. Reagents and kits account for the largest product share, owing to the fresh chemistry that every sample consumes, while polymerase chain reaction remains the largest technology because of its speed and low cost per sample. Analysis software expands fastest among product groups, as laboratories license tools for each platform.

Purchasing criteria are shifting. Laboratories now ask suppliers for performance data and content that matches the people they test, and large buyers compare the price of each result from arrays, polymerase chain reaction, and low pass sequencing before they sign multiyear contracts.

Reimbursement and regulation hold back parts of the market. Coverage for broader panels is uneven, and the rules for laboratory developed tests keep changing, and therefore clinical adoption advances faster in some countries than in others.

Regions behave differently. North America is the largest region, with 40.0% of 2026 revenue, as drug developers and reference laboratories based in the country dominate large orders. Asia Pacific demonstrates the quickest growth, with 14.6% a year from 2026 to 2034, since national genome programs are scaling up in China, India, South Korea, and Australia. Europe is shaped by academic cohorts and strong breeding industries.

Sequencing leads technology growth and pharmacogenomics leads application growth, while copy number variations grow fastest among variant types, at 15.7% a year, owing to arrays and sequencers that can both count gains and losses of DNA segments.

Competition spans instrument makers, kit makers, and service laboratories. Recent moves demonstrate the direction, with Illumina closing its SomaLogic acquisition and Standard BioTools selling its microfluidics unit, both within the past year.

Questions? Request a sample or make an inquiry before buying this report by clicking the link below: Genotyping Assays Market Report

The report examines product, technology, application, end user, and variant type, and adds growth drivers, restraints, openings, trends, and company profiles.

Genotyping Assays Market Report Highlights

North America is the largest region, with 40.0% of 2026 revenue.
Asia Pacific is the fastest growing region, with a CAGR of 14.6% from 2026 to 2034.
Europe ranks third by revenue at 24.3% of the 2026 total, with Germany the biggest national market.
Reagents and Kits held 46.9% of product revenue in 2026.
Sequencing is projected to grow at a CAGR of 18.2% from 2026 to 2034.
Pharmacogenomics was worth USD 6,055 Million in 2026.
Pharmaceutical and Biopharmaceutical Companies is projected to grow at a CAGR of 13.8% from 2026 to 2034.
Diagnostic and Research Laboratories supplied 32.2% of end user revenue in 2026.
Single Nucleotide Polymorphisms held 60.6% of variant type revenue in 2026.
Leading names include Thermo Fisher Scientific Inc., Illumina, Inc., and QIAGEN N.V., alongside specialists such as Mission Bio.

Genotyping Assays Market report by product, technology, application, end user, variant type, and region.

By Product

Reagents and Kits
Instruments
Software and Bioinformatics
Genotyping Services

By Technology

Polymerase Chain Reaction
Microarrays
Sequencing
Capillary Electrophoresis
Mass Spectrometry
Others

By Application

Pharmacogenomics
Diagnostics and Personalized Medicine
Agricultural Biotechnology
Animal Genetics
Drug Discovery and Development
Others

By End User

Pharmaceutical and Biopharmaceutical Companies
Diagnostic and Research Laboratories
Academic and Research Institutes
Agricultural and Animal Breeding Organizations
Other End Users

By Variant Type

Single Nucleotide Polymorphisms
Insertions and Deletions
Copy Number Variations
Short Tandem Repeats
Other Variants

By Region

North America: United States, Canada, Mexico
Europe: Germany, United Kingdom, France, Italy, Spain, Netherlands, Rest of Europe
Asia Pacific: China, Japan, India, South Korea, Australia, Taiwan, Rest of Asia Pacific
Latin America: Brazil, Argentina, Rest of Latin America
Middle East & Africa: Saudi Arabia, United Arab Emirates, Israel, South Africa, Rest of Middle East & Africa